Anti-GSTA2 monoclonal antibody
Pre-made anti-GSTA2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to GSTA2/GSTA2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T53510-Ab-1/ GM-Tg-hg-T53510-Ab-2 | Anti-Human GSTA2 monoclonal antibody | Human |
GM-Tg-rg-T53510-Ab-1/ GM-Tg-rg-T53510-Ab-2 | Anti-Rat GSTA2 monoclonal antibody | Rat |
GM-Tg-mg-T53510-Ab-1/ GM-Tg-mg-T53510-Ab-2 | Anti-Mouse GSTA2 monoclonal antibody | Mouse |
GM-Tg-cynog-T53510-Ab-1/ GM-Tg-cynog-T53510-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GSTA2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T53510-Ab-1/ GM-Tg-felg-T53510-Ab-2 | Anti-Feline GSTA2 monoclonal antibody | Feline |
GM-Tg-cang-T53510-Ab-1/ GM-Tg-cang-T53510-Ab-2 | Anti-Canine GSTA2 monoclonal antibody | Canine |
GM-Tg-bovg-T53510-Ab-1/ GM-Tg-bovg-T53510-Ab-2 | Anti-Bovine GSTA2 monoclonal antibody | Bovine |
GM-Tg-equg-T53510-Ab-1/ GM-Tg-equg-T53510-Ab-2 | Anti-Equine GSTA2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T53510-Ab-1/ GM-Tg-hg-T53510-Ab-2; GM-Tg-rg-T53510-Ab-1/ GM-Tg-rg-T53510-Ab-2; GM-Tg-mg-T53510-Ab-1/ GM-Tg-mg-T53510-Ab-2; GM-Tg-cynog-T53510-Ab-1/ GM-Tg-cynog-T53510-Ab-2; GM-Tg-felg-T53510-Ab-1/ GM-Tg-felg-T53510-Ab-2; GM-Tg-cang-T53510-Ab-1/ GM-Tg-cang-T53510-Ab-2; GM-Tg-bovg-T53510-Ab-1/ GM-Tg-bovg-T53510-Ab-2; GM-Tg-equg-T53510-Ab-1/ GM-Tg-equg-T53510-Ab-2 |
Products Name | Anti-GSTA2 monoclonal antibody |
Format | mab |
Target Name | GSTA2 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-GSTA2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-T53510-Ag-1 | Recombinant multi-species GSTA2/ GST2-2/ GTA2 protein |
ORF Viral Vector | pGMLP004021 | human GSTA2 Lentivirus plasmid |
ORF Viral Vector | vGMLP004021 | human GSTA2 Lentivirus particle |
ORF Viral Vector | pGMLPm000380 | mouse Gsta2 Lentivirus plasmid |
ORF Viral Vector | vGMLPm000380 | mouse Gsta2 Lentivirus particle |
Target information
Target ID | GM-T53510 |
Target Name | GSTA2 |
Gene ID | 2939 |
Gene Symbol and Synonyms | GST2,GSTA2,GSTA2-2,GTA2,GTH2 |
Uniprot Accession | P09210 |
Uniprot Entry Name | GSTA2_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000244067 |
Target Classification | N/A |
The target: GSTA2, gene name: GSTA2, also named as GST2-2, GTA2, GTH2, GSTA2. Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. These enzymes function in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding these enzymes are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of some drugs. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-tranferase belonging to the alpha class. The alpha class genes, located in a cluster mapped to chromosome 6, are the most abundantly expressed glutathione S-transferases in liver. In addition to metabolizing bilirubin and certain anti-cancer drugs in the liver, the alpha class of these enzymes exhibit glutathione peroxidase activity thereby protecting the cells from reactive oxygen species and the products of peroxidation. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.